ArticleTherapeutic advances in gastroenterology2026

Efficacy and health-related quality of life associated with second-line vedolizumab after first-line treatment with one anti-TNF in patients with ulcerative colitis: a meta-analysis of the GEMINI-1 and VISIBLE-1 trials.

Raja Atreya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.